Joseph Truitt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph Truitt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph Truitt. Joseph Truitt is Chief Executive Officer in BIOSPECIFICS TECHNOLOGIES CORP ($BSTCE) and Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and Chief Executive Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and EVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and SVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and VP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and Director in Larimar Therapeutics, Inc. ($ZFGN).
Latest Insider Trading Transactions of Joseph Truitt
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, BSTCE, LRMR
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2020 | ZFGN | Larimar Therapeuti ... | Truitt Joseph | Director | Option Exercise | A | 11.90 | 16,600 | 197,540 | 16,600 | |
| May 29 2020 | BSTCE | BIOSPECIFICS TECHN ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 63.72 | 130,000 | 8,283,600 | 130,000 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.18 | 1,097,000 | 2,391,460 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.90 | 419,000 | 1,215,100 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.02 | 200,000 | 604,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.10 | 87,766 | 272,075 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.66 | 30,000 | 109,800 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.78 | 632,000 | 2,388,960 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 4.11 | 185,000 | 760,350 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 7.59 | 100,000 | 759,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 7.61 | 142,000 | 1,080,620 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | D | 6.30 | 3,500 | 22,050 | 0 | 3.5 K to 0 (-100.00 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | M | 3.10 | 100,234 | 310,725 | 87,766 | |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | M | 3.28 | 33,250 | 109,060 | 0 | |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | S | 6.37 | 33,250 | 211,965 | 3,500 | 36.8 K to 3.5 K (-90.48 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | S | 6.37 | 100,234 | 638,982 | 36,750 | 137 K to 36.8 K (-73.17 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Buy | M | 3.28 | 33,250 | 109,060 | 136,984 | 103.7 K to 137 K (+32.05 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Buy | M | 3.10 | 100,234 | 310,725 | 103,734 | 3.5 K to 103.7 K (+2,863.83 %) |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 2.18 | 1,097,000 | 2,391,460 | 1,097,000 | |
| May 03 2018 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 3.78 | 632,000 | 2,388,960 | 632,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Option Exercise | A | 2.90 | 419,000 | 1,215,100 | 419,000 | |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Buy | P | 4.06 | 3,500 | 14,210 | 3,500 | 0 to 3.5 K |
| Jan 22 2016 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Option Exercise | A | 7.61 | 142,000 | 1,080,620 | 142,000 | |
| Dec 04 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | A | 13.24 | 110,000 | 1,456,400 | 110,000 | |
| Aug 26 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 25,000 | 20,500 | 0 | |
| Aug 26 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 10.82 | 25,000 | 270,500 | 0 | 25 K to 0 (-100.00 %) |
| Aug 26 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 25,000 | 20,500 | 25,000 | 0 to 25 K |
| Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 25,000 | 20,500 | 25,000 | |
| Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 7.82 | 25,000 | 195,500 | 0 | 25 K to 0 (-100.00 %) |
| Jun 17 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 25,000 | 20,500 | 25,000 | 0 to 25 K |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 48,950 | 40,139 | 50,000 | |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | M | 0.82 | 1,050 | 861 | 98,950 | |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 6.05 | 48,950 | 296,148 | 0 | 49 K to 0 (-100.00 %) |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 48,950 | 40,139 | 48,950 | 0 to 49 K |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Sell | S | 4.82 | 1,050 | 5,061 | 0 | 1.1 K to 0 (-100.00 %) |
| Jun 11 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Buy | M | 0.82 | 1,050 | 861 | 1,050 | 0 to 1.1 K |
| Mar 06 2014 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | EVP, Chief Commerci ... | Option Exercise | A | 3.66 | 30,000 | 109,800 | 30,000 | |
| Dec 19 2013 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | SVP, Chief Commerci ... | Option Exercise | A | 3.02 | 200,000 | 604,000 | 200,000 | |
| Dec 20 2012 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | SVP, Chief Commerci ... | Option Exercise | A | 8.64 | 145,000 | 1,252,800 | 145,000 | |
| Dec 14 2011 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 7.59 | 100,000 | 759,000 | 100,000 | |
| Dec 20 2010 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 3.10 | 188,000 | 582,800 | 188,000 | |
| Dec 22 2009 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 3.28 | 33,250 | 109,060 | 33,250 | |
| Jan 07 2009 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | VP, Chief Commercia ... | Option Exercise | A | 0.82 | 100,000 | 82,000 | 100,000 |
Page: 1